Edition:
United States

Intercept Pharmaceuticals Inc (ICPT.OQ)

ICPT.OQ on NASDAQ Stock Exchange Global Select Market

62.24USD
22 Nov 2017
Change (% chg)

$0.44 (+0.71%)
Prev Close
$61.80
Open
$61.76
Day's High
$63.38
Day's Low
$61.16
Volume
161,256
Avg. Vol
385,531
52-wk High
$135.59
52-wk Low
$54.98

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 41.33 -2.892
Jun '17 30.89 -3.459
Mar '17 21.05 -3.607
FY 2016 Dec '16 13.81 -4.838
Sep '16 5.18 -3.590
Jun '16 5.52 -3.141
Mar '16 0.44 -5.171
FY 2015 Dec '15 0.45 -3.623
Sep '15 0.44 -2.102
Jun '15 0.44 -1.994
Mar '15 1.45 -1.776
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 18 44.09 48.96 39.40 33.53
Quarter Ending Mar-18 7 49.21 59.67 42.90 60.20
Year Ending Dec-17 20 135.01 142.23 95.00 96.57
Year Ending Dec-18 20 224.62 316.04 138.00 235.35
Earnings (per share)
Quarter Ending Dec-17 18 -3.39 -2.11 -4.29 -3.43
Quarter Ending Mar-18 7 -3.18 -2.54 -3.56 -7.76
Year Ending Dec-17 19 -13.44 -11.15 -16.50 -14.90
Year Ending Dec-18 19 -12.09 -8.15 -15.66 -11.87
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 189.94 34.73
P/E High - Last 5 Yrs. -- 286.25 45.10
P/E Low - Last 5 Yrs. -- 95.51 24.21
Beta -2.02 0.85 0.89
Price to Sales (TTM) 14.59 94.70 5.33
Price to Book (MRQ) 13.99 20.79 5.60
Price to Tangible Book (MRQ) 13.99 24.37 7.13
Price to Cash Flow (TTM) -- 100.38 23.67
% Owned Institutions 78.89 6.10 1.29

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.03
Dividend 5 Year Growth Rate -- 2.03 5.30
Payout Ratio(TTM) -- 104.97 45.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 698.42 5.12 6.92
Sales (TTM) vs TTM 1 Yr. Ago 824.03 28.35 5.14
Sales - 5 Yr. Growth Rate 69.09 33.44 10.37
EPS (MRQ) vs Qtr. 1 Yr. Ago 19.45 -142.83 4.98
EPS (TTM) vs TTM 1 Yr. Ago 4.70 -- --
EPS - 5 Yr. Growth Rate -- 43.56 10.99
Capital Spending - 5 Yr. Growth Rate 140.73 41.29 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.89 2.54
Current Ratio (MRQ) 5.95 5.54 3.56
LT Debt to Equity (MRQ) 315.21 14.59 12.30
Total Debt to Equity (MRQ) 315.21 16.92 18.25
Interest Coverage (TTM) -47.05 -147.23 43.20

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 86.59 44.52 54.70
Gross Margin - 5 Yr. Avg. -- 55.08 52.19
EBITD Margin (TTM) -317.30 -- --
EBITD - 5 Yr. Avg -2,241.82 -212.26 15.65
Operating Margin (TTM) -321.87 -524.92 8.15
Operating Margin - 5 Yr. Avg. -2,394.67 -227.68 11.31
Pre-Tax Margin (TTM) -344.74 -494.06 8.99
Pre-Tax Margin - 5 Yr. Avg. -3,082.43 -227.56 11.72
Net Profit Margin (TTM) -344.74 -491.57 5.22
Net Profit Margin - 5 Yr. Avg. -3,082.43 -230.64 8.00
Effective Tax Rate (TTM) -- 15.48 24.19
Effective Tax Rate - 5 Yr. Avg. -- 19.02 24.05

Efficiency

  Company industry sector
Revenue/Employee (TTM) 234,818 22,242,450 866,827,034
Net Income/Employee (TTM) -809,509 -1,532,938 101,086,499
Receivable Turnover (TTM) -- 32.92 6.13
Inventory Turnover (TTM) -- 2.68 3.53
Asset Turnover (TTM) 0.16 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.78 -8.23 11.40
Return on Assets - 5 Yr. Avg. -66.63 0.01 12.43
Return on Investment (TTM) -59.99 -10.73 14.56
Return on Investment - 5 Yr. Avg. -72.50 3.24 16.28
Return on Equity (TTM) -140.19 -36.69 16.06
Return on Equity - 5 Yr. Avg. -91.12 5.80 17.43
  1 Year 3 Year 5 Year
Sales % 796.87 148.72 69.09
EPS (TTM) % -75.16 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intercept Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.47 1.88 70 77
13 Week -41.80 -45.23 6 40
26 Week -47.04 -50.97 12 67
52 Week -44.28 -52.74 20 47
YTD -42.72 -50.62 17 48
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.83%
# of Holders: 246
Total Shares Held: 19,537,296
3 Mo. Net Change: -1,349,104
# New Positions: 37
# Closed Positions: 53
# Increased Positions: 118
# Reduced Positions: 103
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.